Literature DB >> 22790437

The expression of vascular endothelial growth factor in mast cells promotes the neovascularisation of human pterygia.

Kun Liang1, Zhengxuan Jiang, Bingying Zhao, Jijia Shen, Dake Huang, Liming Tao.   

Abstract

AIMS: To analyse the relationship between mast cells and vascularisation in pterygia and to determine whether mast cells play an important role in the vascularisation of pterygia through the secretion of vascular endothelial growth factor (VEGF).
METHODS: Fifty-two pterygia and forty-four normal conjunctiva samples were obtained. Formalin-fixed, paraffin wax-embedded tissues were analysed by immunohistochemistry with CD31 and VEGF antibodies. Dual-immunofluorescence was used to see the location of mast cells and microvessels. To prove that mast cells have the function of secreting VEGF, we used dual-immunofluorescence, toluidine blue stain and immunohistochemisty study.
RESULTS: Mast cells are located near the microvessels. The numbers of mast cells in pterygia (10.8 ± 2.7) were significantly higher compared with those in conjunctiva (4.7 ± 2.4, p<0.01). The numbers of microvessels in pterygia (20.7 ± 5.4) were also significantly higher than those in conjunctiva (9.3 ± 2.9, p<0.01). There was an association between mast cell count and microvessel density in pterygia (r=0.77, p<0.001). The cells were positive for toluidine blue staining and could express VEGF through a serial section stain. Dual-immunofluorescence showed that VEGF and mast cell tryptase (MCT) were expressed in the same cell.
CONCLUSION: The results suggest that mast cells have a function in the vascularisation of pterygia through the secretion of VEGF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22790437     DOI: 10.1136/bjophthalmol-2012-301540

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  4 in total

1.  Triple subconjunctival bevacizumab injection for early corneal recurrent pterygium: one-year follow-up.

Authors:  Angel Nava-Castañeda; Isabel Ulloa-Orozco; Lilia Garnica-Hayashi; Joaquín Hernandez-Orgaz; Maria Carmen Jimenez-Martinez; Yonathan Garfias
Journal:  J Ocul Pharmacol Ther       Date:  2014-11-04       Impact factor: 2.671

2.  Does topical bevacizumab prevent postoperative recurrence after pterygium surgery with conjunctival autografting?

Authors:  Aylin Karalezli; Cem Kucukerdonmez; Yonca A Akova; Bengu Ekinci Koktekir
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

3.  Evaluation of the Systemic Inflammation in Patients with Pterygium: Monocyte-to- High-Density Lipoprotein Cholesterol Ratio and Hematologic Indexes of Inflammation.

Authors:  Selman Belviranli; Refik Oltulu; Ali O Gundogan; Enver Mirza; Mehmet Okka
Journal:  Middle East Afr J Ophthalmol       Date:  2022-04-30

Review 4.  Nanotechnology for angiogenesis: opportunities and challenges.

Authors:  Saeid Kargozar; Francesco Baino; Sepideh Hamzehlou; Michael R Hamblin; Masoud Mozafari
Journal:  Chem Soc Rev       Date:  2020-06-15       Impact factor: 54.564

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.